NR4A1 and breast cancer: Because a greater proportion of men relative to women with breast cancer are hormone receptor-positive, standard adjuvant tamoxifen is recommended postoperatively and has shown benefits in patients with hormone-positive tumors after lumpectomy with negative margins [14–16].